Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration. 2006

Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
Neurology & GI CEDD, GlaxoSmithKline Pharmaceuticals, Harlow, Essex CM19 5AW, UK. leann.p.quinn@gsk.com

The automated behavioural apparatus, LABORAS (Laboratory Animal Behaviour Observation, Registration and Analysis System), has been further validated with respect to the ability of the system to detect behavioural impairments in mice, following various dopaminergic manipulations. Initially data were obtained from mice administered with amphetamine, haloperidol, SCH23390, apomorphine and L-DOPA, with the focus on locomotor and grooming activities. The data recorded by LABORAS on administration of these pharmacological tool compounds, is comparable with published findings using standard LMA systems and conventional observer methods. In addition the home cage behaviour of mice administered with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) using an acute dosing regimen was also investigated. In LABORAS, mice subjected to MPTP lesioning showed deficits in spontaneous motor activity at day 6-7 post-MPTP administration, over a 24 h test period, as compared to saline treated controls. The data captured and analysed using LABORAS, suggests that the automated system is able to detect both pharmacologically and lesion-induced changes in behaviour of mice, reliably and efficiently.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009410 Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. Neuron Degeneration,Degeneration, Nerve,Degeneration, Neuron,Degenerations, Nerve,Degenerations, Neuron,Nerve Degenerations,Neuron Degenerations
D011589 Psychology, Experimental The branch of psychology which seeks to learn more about the fundamental causes of behavior by studying various psychologic phenomena in controlled experimental situations. Experimental Psychology,Experimental Psychologies,Psychologies, Experimental
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries

Related Publications

Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
March 2002, Neuropharmacology,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
January 2003, Neuroscience,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
January 2012, Neurobiology of disease,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
July 1968, The Journal of physiology,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
October 2016, Molecular neurobiology,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
October 2018, Neurotoxicity research,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
October 1998, Proceedings of the National Academy of Sciences of the United States of America,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
January 1977, Neuropharmacology,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
April 2010, Neuroscience,
Leann P Quinn, and Tania O Stean, and Helen Chapman, and Matthew Brown, and Martin Vidgeon-Hart, and Neil Upton, and Andrew Billinton, and David J Virley
January 2004, Experimental neurology,
Copied contents to your clipboard!